Page last updated: 2024-09-04

cilomilast and Aging

cilomilast has been researched along with Aging in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benincosa, LJ; Clark, DJ; Cowley, H; Fuder, H; Kelly, J; Murdoch, RD; Port, A; Upward, J; Webber, DM; Wyld, P; Zussman, BD1

Trials

1 trial(s) available for cilomilast and Aging

ArticleYear
An overview of the pharmacokinetics of cilomilast (Ariflo), a new, orally active phosphodiesterase 4 inhibitor, in healthy young and elderly volunteers.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:9

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Aged; Aged, 80 and over; Aging; Area Under Curve; Bronchodilator Agents; Carboxylic Acids; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Double-Blind Method; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Nitriles; Phosphodiesterase Inhibitors

2001